Published in
Springer, International Journal of Hematology, 3(113), p. 370-380, 2020
DOI: 10.1007/s12185-020-03024-3
Links
Tools
Phase 1/2 study of venetoclax, a BCL-2 inhibitor, in Japanese patients with relapsed or refractory chronic lymphocytic leukemia and small lymphocytic lymphoma
Journal article published in 2020 by
Koji Izutsu 
,
Kazuhito Yamamoto,
Koji Kato,
Takayuki Ishikawa,
Noriko Fukuhara,
Yasuhito Terui,
Ilseung Choi,
Kathryn Humphrey,
Su Young Kim,
Sumiko Okubo,
Natsumi Ogawa,
Yasuko Nishimura,
Ahmed Hamed Salem,
Dai Maruyama
,
Kazuhito Yamamoto,
Koji Kato,
Takayuki Ishikawa,
Noriko Fukuhara,
Yasuhito Terui,
Ilseung Choi,
Kathryn Humphrey,
Su Young Kim,
Sumiko Okubo,
Natsumi Ogawa,
Yasuko Nishimura,
Ahmed Hamed Salem,
Dai Maruyama
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 